Deutsche Bank analyst Justin Bowers downgrades Amedisys (NASDAQ:AMED) from Buy to Hold and maintains the price target from $101 to $101.
Deutsche Bank Downgrades Amedisys to Hold, Maintains Price Target to $101
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.